Figures computed from official regulatory filings — methodology.
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
Create a free accountThis page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | |
|---|---|---|---|
| Award | $0 | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $250K | SEC | |
| ExerciseD | $0 | SEC | |
| Exercise | $277.9K | SEC | |
| Award | $0 | SEC | |
| Award | $0 | SEC | |
| Award | $0 | SEC | |
| Award | $0 | SEC | |
| Award | $0 | SEC | |
| Buy | $13.5K | SEC | |
| Buy | $13.6K | SEC | |
| Exercise | $50K | SEC | |
| ExerciseD | $0 | SEC | |
| Award | $0 | SEC | |
| Buy | $23K | SEC | |
| Buy | $8.8K | SEC | |
| Buy | $11.5K | SEC | |
| Buy | $2.6K | SEC | |
| Buy | $11.5K | SEC | |
| Buy | $23.2K | SEC | |
| Buy | $24K | SEC | |
| Buy | $11.9K | SEC | |
| Buy | $13.3K | SEC | |
| Buy | $23.4K | SEC |